Explore Neuroprotective Effect of Lipoic Acid in Amyotrophic Lateral Sclerosis

NCT04518540 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: lipoic acid group
DRUG: control group

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University